Satellos Bioscience Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
SEC Category
Emerging growth company
State of Incorporation
Canada (Federal Level)
Business Address
ROYAL BANK PLAZA, S. TOWER, 200 BAY ST., TORONTO, A6, M5J 2J1
Mailing Address
ROYAL BANK PLAZA, S. TOWER, 200 BAY ST., TORONTO, A6, M5J 2J1
Phone
416-708-0522
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 40-F Canadian company annual report | March 27, 2026 | View on SEC |
| 6-K Foreign company current report | March 27, 2026 | View on SEC |
| 6-K Foreign company current report | March 10, 2026 | View on SEC |
| 6-K Foreign company current report | February 24, 2026 | View on SEC |
| 6-K Foreign company current report | February 19, 2026 | View on SEC |
| 6-K Foreign company current report | February 18, 2026 | View on SEC |
| 6-K Foreign company current report | February 17, 2026 | View on SEC |
| 6-K Foreign company current report | February 12, 2026 | View on SEC |
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
Annual Reports
40-F
March 27, 2026
- Developing SAT-3247, a promising oral treatment for Duchenne muscular dystrophy (DMD).
- Successfully raised $25 million USD in capital to fund ongoing clinical development.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.